Dosage and Side Effects
- Pre-treatment renal and hepatic testing for all patients before and during therapy.
- Recommendations for dosage based on patient condition and hospitalization status.
- Administered via intravenous infusion over 30 to 120 minutes.
Common adverse reactions observed include nausea, increased ALT, and increased AST.
What’s Remdesivir for?
Remdesivir Injection treats COVID-19 in adults and pediatric patients at risk of severe symptoms or hospitalization.
How is it given?
Remdesivir is infused intravenously over 30-120 minutes, typically with a loading dose followed by daily maintenance doses.
Common side effects?
Nausea, increased liver enzymes (ALT, AST), and occasional hypersensitivity reactions during or after infusion.
Any medication interactions?
Avoid using Remdesivir with chloroquine or hydroxychloroquine. Patients with poor kidney function should also avoid it.
Safety during pregnancy?
Remdesivir can harm unborn babies, so strict precautions to avoid pregnancy during treatment are essential.